Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001235802-04-000075
Filing Date
2004-03-22
Accepted
2004-03-22 15:48:29
Documents
1
Period of Report
2004-03-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3288
  Complete submission text file 0001235802-04-000075.txt   5070
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 386 COLUMBUS AVE NEW YORK NY 10024
Business Address
HO ANGELA (Reporting) CIK: 0001249628 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 04682433